SWISS NORDIC BIO
| Reference number | |
| Coordinator | DOUBLE BOND PHARMACEUTICAL AB |
| Funding from Vinnova | SEK 15 000 |
| Project duration | January 2020 - February 2020 |
| Status | Completed |
Important results from the project
The company and the company´s products were exposed to investors and potential partners, personal relationships were established with future partners
Expected long term effects
During the event, the CEO had officially met 7 partners and dozens of mingle meetings took place. During discussions, interesting opportunities for company development were found, new contacts with experienced players in the industry were established.
Approach and implementation
Participation in the event was very helpful and effective. The company plans to participate in SWISS Nordic BIO and expand its presence with a presentation.